LifeCycle Pharma (LCP) is an emerging specialty pharmaceutical company, focused on certain cardiovascular indications and organ transplantation in particular. The intention is to approach the transplantation market through our own, hospital-based specialist sales force and to use marketing and sales partners for the cardiovascular indications. We believe that our proprietary MeltDose® technology platform enables us to develop drugs which achieve the same efficacy as currently commercialized drugs, but at lower doses. The results are generally better bioavailability, a reduction in potential interaction with food and other drugs, and in some cases, reduced side effects.
| Website | http://www.lcpharma.com |
| Revenue | $8 million |
| Employees | View employees |
| Address | 499 Thornall St, Fl 3, Edison, New Jersey 08837, US |
| Phone | +1 732-205-1734 |
| Industry | Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Competitors | Amgen, Novartis, AbbVie, Gilead Sciences, Pfizer, Bristol Myers Squibb, Roche, Merck & Co., Inc., Sanofi +45 more (view full list) |
| SIC | SIC Code 2834 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular LifeCycle Pharma Inc employee's phone or email?
LifeCycle Pharma Inc Questions
The LifeCycle Pharma Inc annual revenue was $8 million in 2026.
LifeCycle Pharma Inc is based in Edison, New Jersey.
The NAICS codes for LifeCycle Pharma Inc are [3254, 325, 32, 32541].
The SIC codes for LifeCycle Pharma Inc are [2834, 283, 28].
